The Europe OTC Drug and Dietary Supplement market was valued at US$ 85,835.9 million in 2019 and is projected to reach US$ 141,676.3 million by 2027; it is expected to grow at a CAGR of 6.6% during 2020–2027.
The growth of the OTC Drug and Dietary Supplement market is mainly attributed to the factors such as rising general health issues, and preference of OTC drugs are expected to propel the growth of the market. However, stringent government regulation for OTC drugs is the major factor hindering the market growth.
The Germany has observed the fastest growth in the OTC Drug and Dietary Supplement market within the past few years and is expected to lead the market in Europe during the forecast period. The market for OTC drug and dietary supplements is expected to grow due to growing awareness about health and fitness, the ever-increasing geriatric population, and spending out–of–pocket. Furthermore, innovations and increased product launches have fueled market growth in recent years. The market has experienced increased sales in the products for cold, pain management, gastrointestinal diseases, influenza, and dietary supplements such as vitamins and herbal products.
Germany OTC Drug and Dietary Supplement Market Revenue and Forecast to 2027
(US$ Million)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
EUROPE OTC DRUG AND DIETARY SUPPLEMENT – MARKET SEGMENTATION
OTC drug and Dietary Supplement– By Product
- Cough and Cold Products
- Vitamins and Dietary Supplements
- Analgesics
- Gastrointestinal Products
- Sleep Aids
- Oral Care Products
- Ophthalmic Products
- Antacids
- Feminine Care
- Others
OTC Drug and Dietary Supplement– By Type
- Branded
- Generic
OTC Drug and Dietary Supplement– By Form
- Tablets
- Capsules
- Powders
- Ointments
- Liquid
- Others
OTC Drug and Dietary Supplement – By Distribution Channel
- Hospital and Retail Pharmacies
- Retail Stores
- Online Channels
- Others
By Country
- Germany
- UK
- France
- Italy
- Spain
Company Profiles
- GlaxoSmithKline plc.
- Sanofi
- Johnson and Johnson Services, Inc.
- Abbott
- AbbVie Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Procter & Gamble
- Novartis AG
- Reckitt Benckiser Group Plc
Europe OTC Drug and Dietary Supplement Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 85,835.9 Million |
| Market Size by 2027 | US$ 141,676.3 Million |
| Global CAGR (2020 - 2027) | 6.6% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | Europe
|
| Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Aircraft MRO Market
- Predictive Maintenance Market
- Collagen Peptides Market
- Single Pair Ethernet Market
- Digital Pathology Market
- Water Pipeline Leak Detection System Market
- Passport Reader Market
- Adaptive Traffic Control System Market
- Nuclear Waste Management System Market
- Personality Assessment Solution Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Type, Form, Distribution Channel, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Europe OTC Drug and Dietary Supplement Market
- GlaxoSmithKline plc.
- Sanofi
- Johnson and Johnson Services, Inc.
- Abbott
- AbbVie Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Procter & Gamble
- Novartis AG
- Reckitt Benckiser Group Plc
Get Free Sample For